Literature DB >> 22682754

Heart rate variability during static and dynamic breath-hold dives in elite divers.

Antti M Kiviniemi1, Toni Breskovic, Lovro Uglesic, Benjamin Kuch, Petra Zubin Maslov, Arne Sieber, Tapio Seppänen, Mikko P Tulppo, Zeljko Dujic.   

Abstract

The purpose of this study was to assess the differences in cardiac autonomic modulation during maximal static (SA) and dynamic (DA) underwater apneas. Arterial oxygen saturation (SpO(2)), heart rate (HR) and HR variability (SD1 from Poincaré plot and short-term fractal-like scaling exponent, α(1)) were analyzed at the immersed baseline (3 min) and initial, mid- and end-phases (each 30s) of SA and DA in nine elite breath-hold divers. DA and SA lasted 78 ± 8 and 225 ± 20s (mean ± SEM), respectively, and resulted in similar decrements in end-stage SpO(2) (78 ± 3 and 75 ± 3%, p=0.352). During DA, initial increase in HR (from 80 ± 5 to 122 ± 5 bpm, p<0.001) was followed by gradual decrease towards the baseline at mid-apnea and end-apnea phase (101 ± 6 and 80 ± 8 bpm, respectively). During SA, HR decreased at mid-apnea (from 78 ± 4 to 66 ± 3 bpm, p=0.004) but did not decrease further at end-apnea phase (66 ± 4b pm). Decreased SD1 was observed at the initial phase of DA (from 28 ± 5 to 10 ± 4 ms, p=0.005) being lower compared with SA (24 ± 4 ms, p=0.005). At the end of DA and SA, SD1 tended to increase above the baseline (62 ± 16 and 66 ± 10 ms, p=0.128 and p=0.093, respectively, p=0.602 DA vs. SA). α(1) tended to be higher at the end of DA compared with SA (1.17 ± 0.10 vs. 0.79 ± 0.10, p=0.059). We concluded that apnea blunts the effects of exercise on cardiac vagal activity at the end of DA. However, higher HR during DA compared with SA indicates larger cardiac sympathetic activity during DA, as suggested also by slightly higher α(1).
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22682754     DOI: 10.1016/j.autneu.2012.05.004

Source DB:  PubMed          Journal:  Auton Neurosci        ISSN: 1566-0702            Impact factor:   3.145


  7 in total

1.  Modeling the diving bradycardia: Toward an "oxygen-conserving breaking point"?

Authors:  Guillaume Costalat; Aurélien Pichon; Fabrice Joulia; Frédéric Lemaître
Journal:  Eur J Appl Physiol       Date:  2015-02-18       Impact factor: 3.078

2.  The current use of wearable sensors to enhance safety and performance in breath-hold diving: A systematic review.

Authors:  Giovanni Vinetti; Nicola F Lopomo; Anna Taboni; Nazzareno Fagoni; Guido Ferretti
Journal:  Diving Hyperb Med       Date:  2020-03-31       Impact factor: 0.887

3.  Acute Cardiovascular and Metabolic Effects of Different Warm-Up Protocols on Dynamic Apnea.

Authors:  Luca Vitali; Milena Raffi; Alessandro Piras
Journal:  J Sports Sci Med       Date:  2022-06-01       Impact factor: 4.017

4.  β1-Blockade increases maximal apnea duration in elite breath-hold divers.

Authors:  Ryan L Hoiland; Philip N Ainslie; Anthony R Bain; David B MacLeod; Mike Stembridge; Ivan Drvis; Dennis Madden; Otto Barak; Douglas M MacLeod; Zeljko Dujic
Journal:  J Appl Physiol (1985)       Date:  2016-04-28

5.  Ultra-short-term heart rate variability during resistance exercise in the elderly.

Authors:  G P T Arêas; F C R Caruso; R P Simões; V Castello-Simões; R B Jaenisch; T O Sato; R Cabiddu; R Mendes; R Arena; A Borghi-Silva
Journal:  Braz J Med Biol Res       Date:  2018-05-21       Impact factor: 2.590

6.  Exponential Relationship Between Maximal Apnea Duration and Exercise Intensity in Non-apnea Trained Individuals.

Authors:  Alexandre Guimard; Fabrice Joulia; Fabrice Prieur; Gauthier Poszalczyk; Kader Helme; François J Lhuissier
Journal:  Front Physiol       Date:  2022-01-25       Impact factor: 4.566

7.  The Human Dive Reflex During Consecutive Apnoeas in Dry and Immersive Environments: Magnitude and Synchronicity.

Authors:  Michael Nordine; Anton Schwarz; Renana Bruckstein; Hanns-Christian Gunga; Oliver Opatz
Journal:  Front Physiol       Date:  2022-01-04       Impact factor: 4.566

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.